Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-20-004639
Filing Date
2020-05-12
Accepted
2020-05-12 07:16:10
Documents
62
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnxp-10q_033120.htm 10-Q 559894
2 LICENSE AGREEMENT, DATED MAY 5, 2020 ex10-1.htm EX-10.1 101909
3 RESEARCH SERVICE AGREEMENT, MAY 6, 2020 ex10-2.htm EX-10.2 76015
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-01.htm EX-31.01 14476
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-02.htm EX-31.02 14372
6 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER ex32-01.htm EX-32.01 8425
  Complete submission text file 0001387131-20-004639.txt   3702873

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tnxp-20200331.xml EX-101.INS 553937
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tnxp-20200331.xsd EX-101.SCH 41739
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tnxp-20200331_cal.xml EX-101.CAL 41192
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tnxp-20200331_def.xml EX-101.DEF 180064
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tnxp-20200331_lab.xml EX-101.LAB 328246
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tnxp-20200331_pre.xml EX-101.PRE 257950
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 20867028
SIC: 2834 Pharmaceutical Preparations